An antibody–drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer

被引：0
|
作者：
Joan Jacob
Liezl E. Francisco
Treena Chatterjee
Zhengdong Liang
Shraddha Subramanian
Qingyun J. Liu
Julie H. Rowe
Kendra S. Carmon
机构：
[1] University of Texas Health Science Center at Houston,Center for Translational Cancer Research, The Brown Foundation Institute of Molecular Medicine
[2] University of Texas Health Science Center at Houston,Department of Internal Medicine, McGovern Medical School
来源：
British Journal of Cancer | 2023年 / 128卷 / 8期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1592 / 1602
页数：10
相关论文
共 50 条
  • [21] Therapeutically targeting endometrial cancer in preclinical models by ICAM1 antibody-drug conjugates
    Xie, Hanfei
    Sun, Lu
    Yao, Shili
    Tian, Xuefei
    Jin, Liming
    Dai, Yujie
    Li, Yuanzheng
    Li, Yuxuan
    Fang, Jianmin
    Guo, Peng
    Zhang, Yingli
    GYNECOLOGIC ONCOLOGY, 2025, 196 : 16 - 27
  • [22] Antitumor activity of Antibody-Drug Conjugates targeting cancer-expressed EGFR in Preclinical Models
    Fitzgerald, D.
    Ho, E. C. H.
    Miller, E.
    Qiu, R.
    Antignani, A.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S86 - S87
  • [23] CCR5-001, a novel drug Fc-conjugate (DFC) targeting CCR5, demonstrates potent efficacy in a colorectal cancer mouse model
    Dohrmann, Simon
    Levin, James
    Dedeic, Nicholas
    Almaguer, Amanda
    Zuill, Doug
    Abelovski, Elizabeth
    Locke, Jeffrey B.
    Fortier, Joanne
    Hernandez, Maria
    Zhao, Qiping
    Amundson, Karin
    Moniz, Madison
    Chen, Hongyuan
    Panickar, Dhanya
    Thanh Lam
    Hough, Grayson
    Brady, Thomas P.
    Borchardt, Allen
    Cole, Jason N.
    Tari, Leslie W.
    CANCER RESEARCH, 2024, 84 (06)
  • [24] Preclinical evaluation of a novel MET antibody-drug conjugate in uveal melanoma models
    Surriga, Oliver
    DaSilva, John
    Schwartz, Gary K.
    CANCER RESEARCH, 2019, 79 (13)
  • [25] ZW251, a novel glypican-3-targeting antibody-drug conjugate bearing a topoisomerase I inhibitor payload demonstrates compelling preclinical activity in hepatocellular carcinoma models
    Madera, L.
    Wu, A.
    Bissessur, A.
    Chan, A.
    Cheng, C. W.
    Yin, K.
    Alonzo, D. A.
    Tsui, J.
    Sim, D.
    Wu, K.
    Urosev, D.
    Petersen, M. E.
    Hershberger, S.
    Stahl, K.
    Rojas, A. Hernandez
    Fung, V.
    Colombo, R.
    Barnscher, S. D.
    Rich, J. R.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S70 - S70
  • [26] DS-6000a, a novel CDH6-targeting antibody-drug conjugate with a novel DNA topoisomerase I inhibitor DXd, demonstrates potent antitumor activity in preclinical models
    Suzuki, H.
    Nagase, S.
    Saito, C.
    Nagata, M.
    Kaneda, Y.
    Honda, K.
    Nishiya, Y.
    Honda, T.
    Nakada, T.
    Goto, R.
    Ishizaka, T.
    Myobatake, Y.
    Abe, Y.
    Agatsuma, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S363 - S364
  • [27] DS-1062a, a novel TROP2-targeting antibody-drug conjugate with a novel DNA topoisomerase I inhibitor DXd, demonstrates potent antitumor activity in preclinical models
    Okajima, Daisuke
    Yamaguchi, Junko
    Kitamura, Michiko
    Kamei, Reiko
    Maejima, Takanori
    Shibutani, Tomoko
    Yasuda, Satoru
    Toki, Tadashi
    Karibe, Tsuyoshi
    Fujitani, Tomomichi
    Nakada, Takashi
    Goto, Riki
    Noguchi, Yutaka
    Abe, Yuki
    Agatsuma, Toshinori
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [28] Preclinical Efficacy and Safety Assessment of an Antibody-Drug Conjugate Targeting the c-RET Proto-Oncogene for Breast Carcinoma
    Minh Nguyen
    Miyakawa, Shuichi
    Kato, Junichi
    Mori, Toshiyuki
    Arai, Toshimitsu
    Armanini, Mark
    Gelmon, Karen
    Yerushalmi, Rinat
    Leung, Samuel
    Gao, Dongxia
    Landes, Gregory
    Haak-Frendscho, Mary
    Elias, Kathleen
    Simmons, Andrew D.
    CLINICAL CANCER RESEARCH, 2015, 21 (24) : 5552 - 5562
  • [29] CX-2043, an EpCAM-targeting probody drug conjugate, demonstrates anti-tumor activity with a favorable safety profile in preclinical models
    Liu, B.
    Shen, J.
    Yu, W.
    Jing, C.
    Saha, S.
    Rangan, V.
    Richardson, J.
    Liu, Y.
    Boule, S.
    Lucas, J.
    Ab, O.
    Hicks, S.
    Belvin, M.
    Kavanaugh, M.
    Schleyer, S.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S15 - S15
  • [30] Significant Therapeutic Efficacy with Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer (vol 56, pg 1239, 2015)
    Vassileva
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (11) : 1807 - 1807
12345